Multinational pharmas’s series of administrative actions from MFDS

Published: 2017-01-18 13:22:41

Updated: 2017-01-18 13:22:41

Multinational pharmaceutical companies have received administrative measures from the Ministry of Food and Drug Safety(MFDS) for violating related regulations, such as the Pharmaceutical Affairs Law.

UCB Korea received a warning from the MFDS on the 1^st of January for not taking a proper action to recall its antihypertensive ‘Univasc Tab 7.5mg(moexipril hydrochloride).’

Abbott Korea received ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.